MoneyWorks4Me

Cipla reports 45% rise in Q2 consolidated net profit

27 Oct 2023 Evaluate

Cipla has reported results for second quarter ended September 30, 2023 (Q2FY24). 

The company has reported 42.95% rise in its net profit at Rs 1029.69 crore for Q2FY24 as compared to Rs 720.30 crore for the same quarter in the previous year. Total income of the company increased by 14.76% at Rs 4869.81 crore for Q2FY24 as compared Rs 4243.55 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 44.89% rise in its net profit at Rs 1155.37 crore for the quarter under review as compared to Rs 797.41 crore for the same quarter in the previous year. Total income of the company increased by 15.17% at Rs 6854.47 crore for Q2FY24 as compared Rs 5951.49 crore for the corresponding quarter previous year.

Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..